Cargando…

Positive-case follow up for lymphatic filariasis after a transmission assessment survey in Haiti

BACKGROUND: Lymphatic filariasis (LF) has been targeted for global elimination as a public health problem since 1997. The primary strategy to interrupt transmission is annual mass drug administration (MDA) for ≥5 years. The transmission assessment survey (TAS) was developed as a decision-making tool...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hast, Marisa A., Javel, Alain, Denis, Eurica, Barbre, Kira, Rigodon, Jonas, Robinson, Keri, Brant, Tara A., Wiegand, Ryan, Gass, Katherine, Telfort, Marc Aurèle, Dubray, Christine
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8906642/ https://www.ncbi.nlm.nih.gov/pubmed/35213537 http://dx.doi.org/10.1371/journal.pntd.0010231

Ejemplares similares

The rationale and cost-effectiveness of a confirmatory mapping tool for lymphatic filariasis: Examples from Ethiopia and Tanzania
por: Gass, Katherine M., et al.
Publicado: (2017)

Willingness to pay for prevention and treatment of lymphatic filariasis in Leogane, Haiti
por: Rheingans, Richard D, et al.
Publicado: (2004)

Translating Research into Reality: Elimination of Lymphatic Filariasis from Haiti
por: Lammie, Patrick J., et al.
Publicado: (2017)

Simulating the effect of evaluation unit size on eligibility to stop mass drug administration for lymphatic filariasis in Haiti
por: Kostandova, Natalya, et al.
Publicado: (2022)

Safety and efficacy of co-administered diethylcarbamazine, albendazole and ivermectin during mass drug administration for lymphatic filariasis in Haiti: Results from a two-armed, open-label, cluster-randomized, community study
por: Dubray, Christine L., et al.
Publicado: (2020)

Notes from the Field: Impact of a Mass Drug Administration Campaign Using a Novel Three-Drug Regimen on Lymphatic Filariasis Antigenemia — American Samoa, 2019
por: Hast, Marisa A., et al.
Publicado: (2020)

Comparison of antigen and antibody responses in repeat lymphatic filariasis transmission assessment surveys in American Samoa
por: Won, Kimberly Y., et al.
Publicado: (2018)

Use of Antibody Tools to Provide Serologic Evidence of Elimination of Lymphatic Filariasis in The Gambia
por: Won, Kimberly Y., et al.
Publicado: (2018)

Secondary Mapping of Lymphatic Filariasis in Haiti-Definition of Transmission Foci in Low-Prevalence Settings
por: Drexler, Naomi, et al.
Publicado: (2012)

Haiti National Program for the Elimination of Lymphatic Filariasis—A Model of Success in the Face of Adversity
por: Oscar, Roland, et al.
Publicado: (2014)

Investigation of Four Cases of Stevens–Johnson Syndrome among Participants in a Mass Drug Administration Campaign with Sulfadoxine-Pyrimethamine and Primaquine in Haiti, 2020
por: Chang, Michelle A., et al.
Publicado: (2023)

A Community-Based Study of Factors Associated with Continuing Transmission of Lymphatic Filariasis in Leogane, Haiti
por: Boyd, Alexis, et al.
Publicado: (2010)

Mass Drug Administration for the Elimination of Lymphatic Filariasis — Port-au-Prince, Haiti, 2011–2012
por: Streit, Thomas, et al.
Publicado: (2013)

Partnering for impact: Integrated transmission assessment surveys for lymphatic filariasis, soil transmitted helminths and malaria in Haiti
por: Knipes, Alaine Kathryn, et al.
Publicado: (2017)

Detecting infection hotspots: Modeling the surveillance challenge for elimination of lymphatic filariasis
por: Harris, Julie R., et al.
Publicado: (2017)

MDA—Lymphatic Filariasis
por: Ichimori, Kazuyo
Publicado: (2014)

Urban lymphatic filariasis
por: Simonsen, Paul E., et al.
Publicado: (2012)

Potential use of antibodies to provide an earlier indication of lymphatic filariasis resurgence in post–mass drug ad ministration surveillance in American Samoa
por: Cadavid Restrepo, Angela M., et al.
Publicado: (2022)

Polisye Kont Moustik: A Culturally Competent Approach to Larval Source Reduction in the Context of Lymphatic Filariasis and Malaria Elimination in Haiti
por: Bardosh, Kevin Louis, et al.
Publicado: (2017)

Endpoints for Lymphatic Filariasis Programs
por: Grady, Caroline A., et al.
Publicado: (2007)

Mapping of lymphatic filariasis in Nepal
por: Sherchand, Jeevan B, et al.
Publicado: (2003)

Elimination of Lymphatic Filariasis in The Gambia
por: Rebollo, Maria P., et al.
Publicado: (2015)

Integrated transmission assessment surveys (iTAS) of lymphatic filariasis and onchocerciasis in Cross River, Taraba and Yobe States, Nigeria
por: Anagbogu, Ifeoma N., et al.
Publicado: (2022)

Evaluation of Lymphatic Filariasis and Onchocerciasis in Three Senegalese Districts Treated for Onchocerciasis with Ivermectin
por: Wilson, Nana O., et al.
Publicado: (2016)

Integrated risk mapping and landscape characterisation of lymphatic filariasis and loiasis in South West Nigeria
por: Brant, Tara A., et al.
Publicado: (2017)

The history of the elimination of lymphatic filariasis in China
por: De-jian, Sun, et al.
Publicado: (2013)

Lymphatic Filariasis Disseminating to the Upper Extremity
por: Maldjian, Catherine, et al.
Publicado: (2014)

The burden of mental health in lymphatic filariasis
por: Ton, Thanh G.N., et al.
Publicado: (2015)

Environmental suitability for lymphatic filariasis in Nigeria
por: Eneanya, Obiora A., et al.
Publicado: (2018)

Review of Dancing Parasites in Lymphatic Filariasis
por: Dietrich, Christoph F., et al.
Publicado: (2019)

Lymphatic filariasis presenting as retroperitoneal cyst
por: Sancheti, Prachi M., et al.
Publicado: (2020)

Evaluating the Evidence for Lymphatic Filariasis Elimination
por: Davis, Emma L., et al.
Publicado: (2019)

Pacific collaboration to eliminate lymphatic filariasis
por: Ichimori, Kazuyo, et al.
Publicado: (2005)

Dosing pole recommendations for lymphatic filariasis elimination: A height-weight quantile regression modeling approach
por: Goss, Charles W., et al.
Publicado: (2019)

Evaluating the Burden of Lymphedema Due to Lymphatic Filariasis in 2005 in Khurda District, Odisha State, India
por: Walsh, Victoria, et al.
Publicado: (2016)

How much will it cost to eradicate lymphatic filariasis? An analysis of the financial and economic costs of intensified efforts against lymphatic filariasis
por: Kastner, Randee J., et al.
Publicado: (2017)

The roles of stakeholder experience and organizational learning in declining mass drug administration coverage for lymphatic filariasis in Port-au-Prince, Haiti: A case study
por: Wodnik, Breanna K., et al.
Publicado: (2020)

Evaluating Molecular Xenomonitoring as a Tool for Lymphatic Filariasis Surveillance in Samoa, 2018–2019
por: McPherson, Brady, et al.
Publicado: (2022)

The geographical distribution of lymphatic filariasis infection in Malawi
por: Ngwira, Bagrey MM, et al.
Publicado: (2007)

Lymphatic filariasis: A view at pathological diversity
por: Mahalingashetti, Prashant Basavaraj, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_052f06qme0gvtbaorq2tdha4sc